Trial Profile
M518101 phase III 52-Week long term study in plaque psoriasis and palmoplantar keratoderma patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2017
Price :
$35
*
At a glance
- Drugs Pefcalcitol (Primary)
- Indications Palmoplantar keratoderma; Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Maruho
- 06 Jun 2017 Status changed from active, no longer recruiting to completed.
- 08 Jun 2016 New trial record